Investigators assessed the diagnostic performance of AST to Platelet Ratio Index and Fibrosis-4 scores compared with transient elastography evaluation of liver stiffness to detect significant fibrosis or cirrhosis.
Researchers suggest that novel biologicals should be explored as a treatment alternative to hepatitis vaccination for patients who are being treated with immunosuppressive drugs.
Adult heart transplants from hepatitis C virus-positive (HCV+) donors appear safe, with no increased risk for adverse effects on one-year survival.
Researchers found data that showed schistosomiasis does not escalate liver damage in patients who are infected with the hepatitis B virus.
From a nationwide Swedish registry, researchers found data that showed in patients with hepatitis B or C virus infection, the long-term hepatocellular carcinoma risk was lower in patients who were treated with lipophilic statins.
Investigators found data that showed patients with hepatitis C virus infection who had a sustained viral response to treatment with interferon had less incidence of extrahepatic manifestations.
Drug interactions between antiretroviral therapy (ART) and direct-acting antivirals (DAAs) pose a clinical challenge in patients with HIV/hepatitis C virus (HCV) coinfection.
Researchers found data that showed less than 10% of people diagnosed with chronic hepatitis C virus infection received treatment with DAAs.
Several physicians explore the etiology of osteopenia and osteoporosis in patients with HIV and HCV who are undergoing antiretroviral therapy.
In Canada, researchers found data that showed there is a need for mental health and addiction care for patients with hepatitis C infection.
